AngioCor Blumenau
Blumenau, Santa Catarina, Brazil
Doctor in Blumenau, State of Santa Catarina
R. Berta Odebrecht, 66 - Garcia, Blumenau - SC, 89020-430
About AngioCor Blumenau
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Amgen
2
Grifols Therapeutics LLC
1
University of Manitoba
1
Clinical Trials at AngioCor Blumenau
During the past decade, AngioCor Blumenau conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC)
2020-05-20
2021-05-17
Completed
1,200
Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)
2021-01-29
2022-01-28
Terminated
57
A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)
2022-04-19
2024-01-05
Recruiting
40,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "AngioCor Blumenau"
#1 collaborator was "University Health Network, Toronto" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at AngioCor Blumenau
According to Clinical.Site data, the most researched conditions in "AngioCor Blumenau" are
"COVID-19" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Pneumonia" (1 trials). Many other conditions were trialed in "AngioCor Blumenau" in a lesser frequency.
Clinical Trials Intervention Types at AngioCor Blumenau
Most popular intervention types in "AngioCor Blumenau" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Evolocumab" (1 trials), "Heparin" (1 trials), "Liquid Alpha1-Proteinase Inhibitor (Human)" (1 trials) and "Lp(a) Screening" (1 trials). Other intervention names were less common.
Clinical Trials Genders at AngioCor Blumenau
The vast majority of trials in "AngioCor Blumenau" are
4 trials for "All" genders.
Clinical Trials Status at AngioCor Blumenau
Currently, there are NaN active trials in "AngioCor Blumenau".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in AngioCor Blumenau,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in AngioCor Blumenau, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".